Cheol Lee J, Hung JY, Kim YC, Chang GC, Soo Yoo S, Yang SH, Davis KL, Nagar SP, Taylor A, Yong Lee S, Shih JY. Real-world treatment patterns in patients with EGFR mutation-positive NSCLC receiving a first line, first- or second-generation EGFR tyrosine kinase inhibitor in South Korea and Taiwan. Asian Pac J Cancer Bio. 2021 May 20;6(2). doi: 10.31557/APJCB.2021.6.2.123-132
Zafeiridi E, McMichael AJ, Passmore AP, McGuinness B. Living alone for people on dementia medication: related use of drugs. Aging (Albany NY). 2020 Oct 21;12(20):20924-9. doi: 10.18632/aging